Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis

To evaluate the efficacy of pirfenidone in patients with rapidly progressive interstitial lung disease (RPILD) related to clinically amyopathic dermatomyositis (CADM), we conducted an open-label, prospective study with matched retrospective controls. Thirty patients diagnosed with CADM-RPILD with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ting, Guo, Li, Chen, Zhiwei, Gu, Liyang, Sun, Fangfang, Tan, Xiaoming, Chen, Sheng, Wang, Xiaodong, Ye, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018967/
https://www.ncbi.nlm.nih.gov/pubmed/27615411
http://dx.doi.org/10.1038/srep33226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018967/
https://www.ncbi.nlm.nih.gov/pubmed/27615411
http://dx.doi.org/10.1038/srep33226

Ejemplares similares